OhMD
Unparalleled patient engagement through text-based patient communication for extraordinary medical practices.
Unparalleled patient engagement through text-based patient communication for extraordinary medical practices.
OhMD is a leading conversational patient engagement software that offers unparalleled patient engagement through text-based communication for remarkable medical practices. Founded in 2014, the company operates in the Health Care and Messaging industries. Its headquarters is based in the United States. OhMD recently secured a significant $4.50M in Seed Round investment on 22 February 2022. The investment was led by prominent investors including FCA Venture Partners, GE Healthcare, Dudley Fund, Marathon Health, and OpenTempo. With its solution allowing for HIPAA compliant texting, OhMD empowers thousands of medical practices and hospitals to elevate patient engagement, enhance satisfaction, and ultimately improve the overall health of their patient population.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $4.50M | 5 |
|
22 Feb 2022 |
| Seed Round | $2.00M | - | 02 Jan 2018 | |
| Seed Round | $1.20M | 1 |
|
02 Mar 2017 |
| Angel Round | $50.00K | - | 12 Mar 2015 | |
| Seed Round | $20.00K | 1 |
|
01 Jul 2014 |
No recent news or press coverage available for OhMD.
We care about your data, and we'd love to use cookies make your experience better.
